Regional

Europe’s Preventable RSV Winter
New ECDC modelling suggests that protecting newborns against RSV could prevent a substantial share of infant hospitalisations during the first months of life. Under a scenario reaching 90% of newborns with long-acting monoclonal antibodies, 61% of RSV hospitalisations in the first two months could be prevented. Europe has the preventive tools. The challenge is making…

Europe Has Plans. Implementation Is Lagging

Food Safety Gets A Political Upgrade

Dengue Policy Goes Regional

Europe’s Infection Gap Starts At The Clinic Door

Europe Made Genomics Mandatory.

Cardiac rehabilitation is now explicitly personalised in Europe. Reimbursement could decide who gets it

Europe Has The Mosquitoes. Not The Tools.

Europe Can Forecast Vibrio Risk. It Still Has To Act.

A CE Mark Is Not Access
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
